Robert Dengler
Impact in
-
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Cancer Genomics and Diagnostics
Papers in
-
- Breast Cancer Treatment Studies 3
- Cancer Genomics and Diagnostics 3
- Protease and Inhibitor Mechanisms 3
-
- Health and Medical Studies 5
- Co-authors
- Bertold Emmerich (5 shared papers)S. Al-Batran (1 shared paper)Stefan Faderl (1 shared paper)Christoph Nerl (1 shared paper)Ulrich Pachmann (3 shared papers)Matthias Rengsberger (2 shared papers)Katharina Pachmann (3 shared papers)Bernd Weiß (1 shared paper)
- Journals
- British Journal of Haematology (1 paper)Neurology (1 paper)The Breast (1 paper)Cost Effectiveness and Resource Allocation (1 paper)Annals of Hematology (1 paper)
- Partner nations
- GermanySpainUnited States
In The Last Decade
Robert Dengler
20 papers receiving 199 citations
Peers
Comparison fields: 5 of 57
- Hematology 48
- Cancer Research 51
- Oncology 87
- Family Practice 6
- Immunology 55
Countries citing papers authored by Robert Dengler
This map shows the geographic impact of Robert Dengler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dengler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dengler more than expected).
Fields of papers citing papers by Robert Dengler
This network shows the impact of papers produced by Robert Dengler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dengler. The network helps show where Robert Dengler may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Dengler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 85 | |
| 2 | 2007 | 29 | |
| 3 | 2017 | 24 | |
| 4 | 2007 | 24 | |
| 5 | 1998 | 7 | |
| 6 | Detection of cathepsin B in tumor cytosol and urine of breast cancer patients. | 1991 | 5 |
| 7 | 1992 | 4 | |
| 8 | 2019 | 4 | |
| 9 | 2016 | 3 | |
| 10 | 2018 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 1995 | 3 | |
| 13 | 2017 | 3 | |
| 14 | Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia. | 1995 | 2 |
| 15 | 2019 | 2 | |
| 16 | 1994 | 2 | |
| 17 | 2006 | 2 | |
| 18 | 2003 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 1 |
About Robert Dengler
Robert Dengler is a scholar working on Cancer Research, General Health Professions, Oncology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 21 papers that have together received 209 indexed citations. Recurring topics across this work include Health and Medical Studies (5 papers), Medical Practices and Rehabilitation (4 papers), Medical and Health Sciences Research (4 papers), Breast Cancer Treatment Studies (3 papers), Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (48 citations), Cancer Research (51 citations), Oncology (87 citations), Family Practice (6 citations) and Immunology (55 citations). Robert Dengler has collaborated with scholars based in Germany, Spain and United States. Frequent co-authors include Bertold Emmerich, S. Al-Batran, Stefan Faderl, Christoph Nerl, Ulrich Pachmann, Matthias Rengsberger, Katharina Pachmann, Bernd Weiß, Uirassu Borges and Torsten Kroll. Their work appears in journals such as British Journal of Haematology, Neurology, The Breast, Cost Effectiveness and Resource Allocation and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.